MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$1,548,194
(-83.53%↓ Y/Y)
Foreign currency
translation adjustment
$12,048
(906.97%↑ Y/Y)
Net loss attributed
to abvc and...
-$1,560,242
(-85.29%↓ Y/Y)
Net loss
attributable to...
-$129,695
(-27.01%↓ Y/Y)
Net loss
-$1,689,937
(-78.98%↓ Y/Y)
Loss before
provision income tax
-$1,689,937
(-78.98%↓ Y/Y)
Loss from operations
-$1,572,472
(-126.91%↓ Y/Y)
Total other income
(expenses)
-$117,465
(53.24%↑ Y/Y)
Operating sublease income
$12,000
(0.00%↑ Y/Y)
Interest income
$3,765
(-80.26%↓ Y/Y)
Total operating
expenses
$1,572,472
(126.91%↑ Y/Y)
Gain (loss) on
foreign exchange...
-$51,156
(-416.10%↓ Y/Y)
Interest expense
$49,377
(-77.85%↓ Y/Y)
Loss on investment in
equity securities
-$31,416
(38.25%↑ Y/Y)
Other income
(expenses)
-$1,281
(-185.40%↓ Y/Y)
Stock-based compensation
$787,374
(1514.36%↑ Y/Y)
Selling, general and
administrative expenses
$751,998
(22.20%↑ Y/Y)
Research and development
expenses
$33,100
(14.69%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ABVC BIOPHARMA, INC. (ABVC)
ABVC BIOPHARMA, INC. (ABVC)